News & Press
Israeli startup raises $28M for injectable hydrogel neural scaffold for spinal cord injury
Calcalist Tech4/5/2026·04/05/26🌐 Europe
Summary
Tel Aviv-based InVivo Therapeutics closed a $28M Series B for their injectable hydrogel neural scaffold combining a biopolymer environment for axonal regrowth with optogenetic activation to guide regenerating neurons across spinal cord injury sites.
Why it matters
Spinal cord repair combining biomaterials and optogenetics is an ambitious but potentially curative approach. Israeli neurotech is increasingly producing systems-level innovations combining multiple cutting-edge technologies.
#Industry#Israel#Optogenetics#Spinal Cord Injury#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in